ArchPoint Investors’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,331
Closed -$220K 57
2022
Q3
$220K Sell
24,331
-1,416
-5% -$12.8K 0.09% 54
2022
Q2
$77K Hold
25,747
0.03% 56
2022
Q1
$173K Hold
25,747
0.06% 56
2021
Q4
$139K Sell
25,747
-2,500
-9% -$13.5K 0.04% 65
2021
Q3
$250K Buy
28,247
+480
+2% +$4.25K 0.07% 86
2021
Q2
$352K Buy
27,767
+629
+2% +$7.97K 0.12% 42
2021
Q1
$471K Buy
+27,138
New +$471K 0.13% 72